1.93
前日終値:
$2.25
開ける:
$2.18
24時間の取引高:
4.04M
Relative Volume:
2.92
時価総額:
$217.77M
収益:
-
当期純損益:
$-134.24M
株価収益率:
-1.0904
EPS:
-1.77
ネットキャッシュフロー:
$-121.34M
1週間 パフォーマンス:
-28.52%
1か月 パフォーマンス:
-26.89%
6か月 パフォーマンス:
-67.40%
1年 パフォーマンス:
-73.08%
Annexon Inc Stock (ANNX) Company Profile
ANNX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ANNX
Annexon Inc
|
1.93 | 217.77M | 0 | -134.24M | -121.34M | -1.77 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-03-01 | アップグレード | JP Morgan | Neutral → Overweight |
2023-12-21 | アップグレード | BofA Securities | Neutral → Buy |
2023-10-30 | 開始されました | Wells Fargo | Overweight |
2023-05-26 | ダウングレード | BofA Securities | Buy → Neutral |
2023-05-25 | ダウングレード | JP Morgan | Overweight → Neutral |
2022-09-16 | 開始されました | Jefferies | Buy |
2022-09-09 | 開始されました | BTIG Research | Buy |
2021-11-30 | 開始されました | H.C. Wainwright | Buy |
2021-09-23 | 開始されました | Cantor Fitzgerald | Overweight |
2021-01-26 | 開始されました | Needham | Buy |
2020-08-18 | 開始されました | BofA Securities | Buy |
2020-08-18 | 開始されました | Cowen | Outperform |
2020-08-18 | 開始されました | JP Morgan | Overweight |
すべてを表示
Annexon Inc (ANNX) 最新ニュース
Here's Why We're Not Too Worried About Annexon's (NASDAQ:ANNX) Cash Burn Situation - Yahoo Finance
135,000 Shares in Annexon, Inc. (NASDAQ:ANNX) Purchased by Swiss National Bank - Defense World
Annexon Inc (NASDAQ: ANNX) Slashes -7.49%: The Most Likely Path Going Forward - Stocks Register
Annexon, Inc. (NASDAQ:ANNX) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Annexon stock hits 52-week low at $2.28 amid market challenges By Investing.com - Investing.com South Africa
Annexon stock hits 52-week low at $2.28 amid market challenges - Investing.com Australia
Bank of New York Mellon Corp Acquires 6,226 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon Inc (NASDAQ: ANNX): Down -60.53% In 2025, Outlook Remains Negative - Stocks Register
Annexon Inc (ANNX) With A Potential Upside Of More Than -460.0% - Stocks Register
Quarterly Metrics: Quick and Current Ratios for Annexon Inc (ANNX) - The Dwinnex
Annexon (ANNX) Projected to Post Earnings on Tuesday - Defense World
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Annexon Strengthens Team with 35,000-Share Stock Option Grant to Key New Hire - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
19,895 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by Arizona State Retirement System - Defense World
Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX) - Seeking Alpha
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of “Buy” by Analysts - Defense World
Rhumbline Advisers Purchases 5,854 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Q1 Earnings Forecast for Annexon Issued By HC Wainwright - Defense World
Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating - TipRanks
Q2 Earnings Estimate for Annexon Issued By HC Wainwright - Defense World
Analysts Set Expectations for Annexon FY2025 Earnings - Defense World
New York State Common Retirement Fund Purchases 20,311 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Potential Price Increase for Annexon Inc (ANNX) After Recent Insider Activity - Knox Daily
Annexon stock price target cut to $20 at H.C. Wainwright By Investing.com - Investing.com Canada
Annexon (NASDAQ:ANNX) Given “Buy” Rating at Needham & Company LLC - Defense World
Gaining Ground: Annexon Inc (ANNX) Closes Lower at 2.39, Down -9.47 - The Dwinnex
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating - TipRanks
Annexon Biosciences Reports Strong Progress in 2024 - MSN
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones - The Manila Times
Annexon reports Q4 EPS (33c), consensus (29c) - TipRanks
Annexon Reports Fourth Quarter and Year-End 2024 Financial - GlobeNewswire
Can Annexon's $312M War Chest Fuel Its Breakthrough Treatments Through 2026? - StockTitan
Annexon stock hits 52-week low at $2.63 amid market challenges - Investing.com Australia
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
What Will Annexon Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan
Annexon stock hits 52-week low at $2.63 amid market challenges By Investing.com - Investing.com South Africa
Annexon stock hits 52-week low at $3.04 amid market challenges - MSN
Annexon, Inc. (NASDAQ:ANNX) CEO Sells $14,811.95 in Stock - MarketBeat
Annexon executive sells shares worth $16,379 By Investing.com - Investing.com South Africa
Annexon EVP Ted Yednock sells $24,283 in stock - Investing.com India
Annexon chief medical officer sells $16,342 in common stock By Investing.com - Investing.com South Africa
Annexon chief medical officer sells $16,342 in common stock - Investing.com
Annexon chief business officer sells $19,523 in company stock By Investing.com - Investing.com Australia
Annexon executive sells shares worth $16,379 - Investing.com
Annexon chief business officer sells $19,523 in company stock - Investing.com
Annexon CFO Jennifer Lew sells shares worth $20,183 By Investing.com - Investing.com South Africa
Annexon CFO Jennifer Lew sells shares worth $20,183 - Investing.com
Annexon Inc (ANNX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):